Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Free Cash Flow (2019 - 2026)

InMed Pharmaceuticals has reported Free Cash Flow over the past 5 years, most recently at -$2.4 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 5.03% year-over-year to -$2.4 million; the TTM value through Dec 2025 reached -$7.4 million, down 1.77%, while the annual FY2025 figure was -$7.8 million, 11.03% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$2.4 million at InMed Pharmaceuticals, down from -$1.6 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$689750.0 in Q2 2023 and troughed at -$5.4 million in Q1 2022.
  • A 5-year average of -$2.3 million and a median of -$2.1 million in 2023 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: surged 82.96% in 2023 and later crashed 72.81% in 2025.
  • Year by year, Free Cash Flow stood at -$3.3 million in 2021, then increased by 18.26% to -$2.7 million in 2022, then skyrocketed by 31.88% to -$1.8 million in 2023, then crashed by 35.39% to -$2.5 million in 2024, then rose by 5.03% to -$2.4 million in 2025.
  • Business Quant data shows Free Cash Flow for INM at -$2.4 million in Q4 2025, -$1.6 million in Q3 2025, and -$1.8 million in Q2 2025.